245 related articles for article (PubMed ID: 34394093)
1. High Frequency Occult Hepatitis B Virus Infection Detected in Non-Resolved Donations Suggests the Requirement of Anti-HBc Test in Blood Donors in Southern China.
Ye X; Zhao Y; Li R; Li T; Zheng X; Xiong W; Zeng J; Xu M; Chen L
Front Immunol; 2021; 12():699217. PubMed ID: 34394093
[TBL] [Abstract][Full Text] [Related]
2. High-Frequency Notable HBV Mutations Identified in Blood Donors With Occult Hepatitis B Infection From Heyuan City of Southern China.
Ye X; Liu L; Chen L; Nie X; Huang L; Ye D; Zeng J; Li T; Li B; Xu M; Chen L
Front Immunol; 2022; 13():754383. PubMed ID: 35634299
[TBL] [Abstract][Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
4. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
[TBL] [Abstract][Full Text] [Related]
5. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool?
Wang L; Chang L; Xie Y; Huang C; Xu L; Qian R; Zhu H; He Y; Li J; Huang H; Li W; Zhang K; Zhang R; Xie J; Sun Y; Li J
Transfusion; 2015 Feb; 55(2):395-404. PubMed ID: 25125223
[TBL] [Abstract][Full Text] [Related]
6. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
7. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
Niederhauser C; Mansouri Taleghani B; Graziani M; Stolz M; Tinguely C; Schneider P
Swiss Med Wkly; 2008 Mar; 138(9-10):134-41. PubMed ID: 18330733
[TBL] [Abstract][Full Text] [Related]
8. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
Houareau C; Offergeld R
Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.
Ren FR; Wang JX; Huang Y; Yao FZ; Lv YL; Li JL; Wen GX; Wen XQ; Liu J; Dong XD; Ma HL; Zhou ZM; Bi XH; Tu L; King M; Nelson K; Ness P; Shan H
Transfusion; 2011 Dec; 51(12):2588-95. PubMed ID: 21682731
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
[TBL] [Abstract][Full Text] [Related]
11. Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy.
Spreafico M; Berzuini A; Foglieni B; Candotti D; Raffaele L; Guarnori I; Colli A; Maldini FF; Allain JP; Prati D
J Hepatol; 2015 Nov; 63(5):1068-76. PubMed ID: 26116791
[TBL] [Abstract][Full Text] [Related]
12. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
15. NAT for HBV and anti-HBc testing increase blood safety.
Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatitis B virus infection in German blood donors 2008-2015.
Scheiblauer H; Heiden M; Funk M; Oberle D; Kreß J; Jork C; Chudy M
Vox Sang; 2020 Apr; 115(3):152-161. PubMed ID: 32023664
[TBL] [Abstract][Full Text] [Related]
17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Stramer SL; Notari EP; Krysztof DE; Dodd RY
Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China.
Ye X; Li T; Li Y; Zeng J; Li R; Xu X; Guan X; Li L
Transfus Med; 2023 Feb; 33(1):81-89. PubMed ID: 36815535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
